Characterizing Methamphetamine Use Among People Who Use Opioids: A Systematic Review

Alammehrjerdi, Z., Ezard, N., Clare, P., & Dolan, K. (2017). Methamphetamine use disorder untreated among women in methadone treatment in Iran. Iranian Journal of Psychiatry and Behavioral Sciences, 11(2), e7861. https://doi.org/10.5812/ijpbs.7861 Al-Tayyib, A., Koester, S., Langegger, S., & Raville, L. (2017). Heroin and methamphetamine injection: An emerging drug use pattern. Substance Use and Misuse, 52(8), 1051–1058. https://doi.org/10.1080/10826084.2016.1271432 American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Publishing, Inc. https://doi.org/10.1176/appi.books.9780890425596 Antoniou, T., Martins, D., Campbell, T., Tadrous, M., Munro, C., Leece, P., Mamdani, M., Juurlink, D. N., & Gomes, T. (2021). Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: A population-based time–series analysis. Addiction, 116(6), 1514–1520. https://doi.org/10.1111/add.15324 Austin, T., & Boyd, J. (2021). Having a voice and saving lives: A qualitative survey on employment impacts of people with lived experience of drug use working in harm reduction. Harm Reduction Journal, 18(1). https://doi.org/10.1186/s12954-020-00453-5 Bach, P., Hayashi, K., Milloy, M., Nosova, E., Kerr, T., Wood, E., & Fairbairn, N. (2020). Characterising the increasing prevalence of crystal methamphetamine use in Vancouver, Canada, from 2006–2017: A gender-based analysis. Drug and Alcohol Review, 39(7), 932–940. https://doi.org/10.1111/dar.13126 Back, S. E., Payne, R., Wahlquist, A. H., Carter, R. E., Stroud, Z., Haynes, L., Hillhouse, M., Brady, K. T., & Ling, W. (2011). Comparative profiles of men and women with opioid dependence: Results from a national multisite effectiveness trial. American Journal of Drug and Alcohol Abuse, 37(5), 313–323. https://doi.org/10.3109/00952990.2011.596982 Baker, R., Leichtling, G., Hildebran, C., Pinela, C., Waddell, E. N., Sidlow, C., Leahy, J., & Korthuis, P. T. (2020). “Like yin and yang”: Perceptions of methamphetamine benefits and consequences among people who use opioids in rural communities. Journal of Addiction Medicine, 15(1), 34–39. https://doi.org/10.1097/adm.0000000000000669 Bardwell, G., Collins, A. B., McNeil, R., & Boyd, J. (2017). Housing and overdose: An opportunity for the scale-up of overdose prevention interventions? Harm Reduction Journal, 14(1), 77. https://doi.org/10.1186/s12954-017-0203-9 BC Coroners Service. (2020). Fentanyl-detected illicit drug toxicity deaths. http://www2.gov.bc.ca/gov/content/safety/public-safety/death-investigation/statistical. Accessed 3 June 2021. Boshears, P., Boeri, M., & Harbry, L. (2011). Addiction and sociality: Perspectives from methamphetamine users in suburban USA. Addiction Research & Theory, 19(4), 289–301. https://doi.org/10.3109/16066359.2011.566654 Brouwer, K. C., Case, P., Ramos, R., Magis-Rodríguez, C., Bucardo, J., Patterson, T. L., & Strathdee, S. A. (2006). Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico. Substance Use and Misuse, 41(5), 707–727. https://doi.org/10.1080/10826080500411478 Brown, H. D., & DeFulio, A. (2020). Contingency management for the treatment of methamphetamine use disorder: A systematic review. Drug and Alcohol Dependence, 216, 108307. https://doi.org/10.1016/j.drugalcdep.2020.108307 Buresh, M., Nahvi, S., Steiger, S., & Weinstein, Z. M. (2022). Adapting methadone inductions to the fentanyl era. Journal of Substance Abuse Treatment, 141(108832). https://doi.org/10.1016/j.jsat.2022.108832 Chan, B., Freeman, M., Ayers, C., Korthuis, P. T., Paynter, R., Kondo, K., & Kansagara, D. (2020). A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders. Drug and Alcohol Dependence, 216, 108193. https://doi.org/10.1016/j.drugalcdep.2020.108193 Choi, N. G., DiNitto, D. M., Marti, C. N., & Choi, B. Y. (2022). U.S. older adults’ heroin and psychostimulant use treatment admissions, 2012–2019: Sociodemographic and clinical characteristics. Drug and Alcohol Dependence, 231, 109256. https://doi.org/10.1016/j.drugalcdep.2021.109256 Chomchai, C., & Chomchai, S. (2015). Global patterns of methamphetamine use. Current Opinion in Psychiatry, 28(4), 269–274. https://doi.org/10.1097/YCO.0000000000000168 Ciccarone, D. (2019). The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis. International Journal of Drug Policy, 71, 183–188. https://doi.org/10.1016/j.drugpo.2019.01.010 Cicero, T. J., Ellis, M. S., & Kasper, Z. A. (2020). Polysubstance use: A broader understanding of substance use during the opioid crisis. American Journal of Public Health, 110(2), 244–250. https://doi.org/10.2105/AJPH.2019.305412 Cohen, B. R., Mahoney, K., Baro, E., Squire, C., Beck, M. J., Travis, S., Pike-McCrudden, A., Izem, R., & Woodcock, J. (2020). FDA initiative for drug facts label for over-the-counter naloxone. The New England Journal of Medicine, 382(22), 2129–2136. https://doi.org/10.1056/nejmsa1912403 Compton, W. M., Jones, C. M., & Underwood, N. (2020). Reducing negative consequences from use of methamphetamine. In Addiction. National Institute on Drug Abuse, National Institutes of Health. Wiley-Blackwell. https://doi.org/10.1111/add.14966 Corser, J., Palis, H., Fleury, M., Lamb, J., Lock, K., McDougall, J., Mehta, A., Newman, C., Spence, H., & Buxton, J. A. (2022). Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: A qualitative study. Harm Reduction Journal, 19(1). https://doi.org/10.1186/s12954-022-00630-8 Corsi, K. F., & Booth, R. E. (2008). HIV sex risk behaviors among heterosexual methamphetamine users: Literature review from 2000 to present. Current Drug Abuse Reviews, 1(3), 292–296. https://doi.org/10.2174/1874473710801030292 Cui, Z., Bach, P., Ti, L., Hayashi, K., Morgan, J., Milloy, M. J., & Kerr, T. (2022a). Opioid agonist therapy engagement and crystal methamphetamine use: The impact of unregulated opioid use in Vancouver, Canada. International Journal of Drug Policy, 110, 103879. https://doi.org/10.1016/j.drugpo.2022.103879 Cui, Z., Hayashi, K., Bach, P., Dong, H., Milloy, M. J., & Kerr, T. (2022b). Predictors of crystal methamphetamine use initiation or re-initiation among people receiving opioid agonist therapy: A prospective cohort study. Drug and Alcohol Dependence, 240, 109624. https://doi.org/10.1016/j.drugalcdep.2022.109624 Cui, Z., Karamouzian, M., Law, M., Hayashi, K., Milloy, M. J., & Kerr, T. (2023). The impact of longitudinal substance use patterns on the risk of opioid agonist therapy discontinuation: A repeated measures latent class analysis. International Journal of Mental Health and Addiction, 1–17. https://doi.org/10.1007/s11469-023-01098-8 Dai, Z., Abate, M. A., Groth, C. P., Rucker, T., Kraner, J. C., Mock, A. R., & Smith, G. S. (2022). Fentanyl and other opioid involvement in methamphetamine-related deaths. American Journal of Drug and Alcohol Abuse, 48(2), 226–234. https://doi.org/10.1080/00952990.2021.1981919 Danesh, A., & Noroozi, A. (2019). Concurrent amphetamine and methamphetamine use among clients of opioid maintenance treatment programs in Golestan, Iran. Iranian Journal of Psychiatry and Behavioral Sciences, 13(2), e74234. https://doi.org/10.5812/ijpbs.74234 Daniulaityte, R., Juhascik, M. P., Strayer, K. E., Sizemore, I. E., Zatreh, M. Y., Nahhas, R. W., Harshbarger, K. E., Antonides, H. M., Martins, S. S., & Carlson, R. G. (2019). Trends in fentanyl and fentanyl analogue-related overdose deaths – Montgomery County, Ohio, 2015–2017. Drug and Alcohol Dependence, 198, 116–120. https://doi.org/10.1016/j.drugalcdep.2019.01.045 Daniulaityte, R., Silverstein, S. M., Crawford, T. N., Martins, S. S., Zule, W., Zaragoza, A. J., & Carlson, R. G. (2020). Methamphetamine use and its correlates among individuals with opioid use disorder in a midwestern U.S. city. Substance Use and Misuse, 55(11), 1781–1789. https://doi.org/10.1080/10826084.2020.1765805 Daniulaityte, R., Silverstein, S. M., Getz, K., Juhascik, M., McElhinny, M., & Dudley, S. (2022). Lay knowledge and practices of methamphetamine use to manage opioid-related overdose risks. International Journal of Drug Policy, 99, 103463. https://doi.org/10.1016/j.drugpo.2021.103463 Daniulaityte, R., Ruhter, L., Juhascik, M., & Silverstein, S. (2023). Attitudes and experiences with fentanyl contamination of methamphetamine: Exploring self-reports and urine toxicology among persons who use methamphetamine and other drugs. Harm Reduction Journal, 20(1), 54. https://doi.org/10.1186/s12954-023-00782-1 Dargan, P. I., & Wood, D. M. (2012). Recreational drug use in the Asia Pacific region: Improvement in our understanding of the problem through the UNODC programmes. Journal of Medical Toxicology, 8(3), 295–299. https://doi.org/10.1007/s13181-012-0240-4 Darke, S. (1998). Self-report among injecting drug users: A review. Drug and Alcohol Dependence, 51(3), 253–263. https://doi.org/10.1016/S0376-8716(98)00028-3 Davis, C. S., & Carr, D. (2020). Over the counter naloxone needed to save lives in the United States. Preventive Medicine, 130, 105932. https://doi.org/10.1016/j.ypmed.2019.105932 Des Jarlais, D. C., Kerr, T., Carrieri, P., Feelemyer, J., & Arasteh, K. (2016). HIV infection among persons who inject drugs: Ending old epidemics and addressing new outbreaks. AIDS (London, England), 30(6), 815–826. https://doi.org/10.1097/QAD.0000000000001039 Des Jarlais, C., Feelemyer, J., Arasteh, K., Huong, D. T., Oanh, K. T. H., Khue, P. M., Giang, H. T., Thanh, N. T. T., Moles, J. P., Hai, V. V., Vallo, R., Quillet, C., Rapoud, D., Laurent, M., Laureillard, D., & Nagot, N. (2021). The methamphetamine epidemic among persons who inject heroin in Hai Phong, Vietnam. Journal of Substance Abuse Treatment, 126, 108320. https://doi.org/10.1016/j.jsat.2021.108320 Dong, H., Yang, M., Liu, L., Zhang, C., Liu, M., Shen, Y., Liu, H., & Hao, W. (2017). Comparison of demographic characteristics and psychiatric comorbidity among methamphetamine-, heroin- and methamphetamine-heroin co-dependent males in Hunan, China. BMC Psychiatry, 17(1). https://doi.org/10.1186/s12888-017-1346-7 Donijan, A. M. (2013). Methamphetamine: Meth Lab Trends and Ingredient Control Efforts. Nova Science Publishers. El Ibrahimi, S., Hallvik, S., Johnston, K., Leichtling, G., Korthuis, P. T., Chan, B., & Hartung, D. M. (2022). Characteristics and health care events of patients admitted to treatment for both heroin and methamphetamine compared to patients admitted for heroin only. Journal of Substance Abuse Treatment, 132, 108615. https://doi.org/10.1016/j.jsat.2021.108615 Ellis, M. S., Kasper, Z. A., & Cicero, T. J. (2018). Twin epidemics: The surging rise of methamphetamine use in chronic opioid users. Drug and Alcohol Dependence, 193, 14–20. https://doi.org/10.1016/j.drugalcdep.2018.08.029 Ellis, M. S., Kasper, Z. A., & Cicero, T. J. (2021). Polysubstance use trends and variability among individuals with opioid use disorder in rural versus urban settings. Preventive Medicine, 152(2), 106729. https://doi.org/10.1016/j.ypmed.2021.106729 EMCDDA. (2021). Polydrug use: health and social responses. https://www.emcdda.europa.eu/publications/mini-guides/polydrug-use-health-and-social-responses_en#section1. EMCDDA. (2022). Signals of spreading methamphetamine use in Europe. https://www.emcdda.europa.eu/publications/eu-drug-markets/methamphetamine/use-in-europe_en. Esmaili, A., Shishehgar, S., & Massah, O. (2019). Methadone maintenance treatment in Iran and brief psychological treatments for women: A rehabilitation approach in methamphetamine dependence. Journal of Rehabilitation, 222–229. https://doi.org/10.32598/rj.20.3.222 Fast, D., Kerr, T., Wood, E., & Small, W. (2014). The multiple truths about crystal meth among young people entrenched in an urban drug scene: A longitudinal ethnographic investigation. Social Science and Medicine, 110, 41–48. https://doi.org/10.1016/j.socscimed.2014.03.029 Fischer, B., O’Keefe-Markman, C., Lee, A. M., & Daldegan-Bueno, D. (2021). ‘Resurgent’, ‘twin’ or ‘silent’ epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America. Substance Abuse Treatment Prevention and Policy, 16(1). https://doi.org/10.1186/s13011-021-00350-5 Forrest, D. W., Metsch, L. R., LaLota, M., Cardenas, G., Beck, D. W., & Jeanty, Y. (2010). Crystal methamphetamine use and sexual risk behaviors among HIV-positive and HIV-negative men who have sex with men in South Florida. Journal of Urban Health, 87(3), 480–485. https://doi.org/10.1007/s11524-009-9422-z Frost, M. C., Lampert, H., Tsui, J. I., Iles-Shih, M. D., & Williams, E. C. (2021). The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: A systematic review. Addiction Science and Clinical Practice, 16(1), 62. https://doi.org/10.1186/s13722-021-00266-2 Gabrovec, B. (2015). The prevalence of methamphetamine, MDMA and new drugs among opiate addicts on agonist opioid treatment. Heroin Addiction and Related Clinical Problems, 17(4), 69–76. Giang, H. T., Duc, N. Q., Molès, J., Vinh, V. H., Nagot, N., Thanh, N. T. T., Huong, D. T., Oanh, K. T. H., Khue, P. M., Sao, L., Thu, T. N., Ngoc, P. T., Quillet, C., Feelemyer, J., Vallo, R., Laurent, M., Jarlais, D. D., Laureillard, D., & Rapoud, D. (2022a). Maintaining HIV and HCV prevention and care for people who inject drugs despite COVID-19 in Hai Phong, Vietnam. International Journal of Drug Policy, 110, 103870. https://doi.org/10.1016/j.drugpo.2022.103870 Giang, L. M., Li, M. J., Okafor, C. N., Diep, N. B., & Shoptaw, S. J. (2022b). Correlates of methamphetamine use severity among patients receiving methadone maintenance treatment for opioid use disorder in Vietnam. Journal of Substance Abuse Treatment, 132, 108461. https://doi.org/10.1016/j.jsat.2021.108461 Glick, S. N., Burt, R., Kummer, K., Tinsley, J., Banta-Green, C. J., & Golden, M. R. (2018). Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington. Drug and Alcohol Dependence, 182, 86–92. https://doi.org/10.1016/j.drugalcdep.2017.10.011 Glick, S. N., Klein, K. S., Tinsley, J., & Golden, M. R. (2021). Increasing heroin-methamphetamine (goofball) use and related morbidity among Seattle area people who inject drugs. American Journal on Addictions, 30(2), 183–191. https://doi.org/10.1111/ajad.13115 Government of Canada. (2022). Opioid- and stimulant-related harms in Canada. Government of Canada. https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/ Haddaway, N. R., Collins, A. M., Coughlin, D., & Kirk, S. (2015). The role of Google Scholar in evidence reviews and its applicability to grey literature searching. PloS ONE, 10(9), e0138237. https://doi.org/10.1371/journal.pone.0138237 Hammett, T. M., Phan, S., Gaggin, J., Case, P., Zaller, N., Lutnick, A., Kral, A. H., Fedorova, E. V., Heimer, R., Small, W., Pollini, R. A., Beletsky, L., Latkin, C. A., & Jarlais, D. C. D. (2014). Pharmacies as providers of expanded health services for people who inject drugs: A review of laws, policies, and barriers in six countries. BMC Health Services Research, 14(1). https://doi.org/10.1186/1472-6963-14-261 Hansen, E. R., Carvalho, S., McDonald, M., & Havens, J. R. (2021). A qualitative examination of recent increases in methamphetamine use in a cohort of rural people who use drugs. Drug and Alcohol Dependence, 229, 109145. https://doi.org/10.1016/j.drugalcdep.2021.109145 Havens, J. R., Knudsen, H. K., Strickland, J. C., Young, A. M., Babalonis, S., Lofwall, M. R., & Walsh, S. L. (2022). Recent increase in methamphetamine use in a cohort of rural people who use drugs: Further evidence for the emergence of twin epidemics. Frontiers in Psychiatry, 12, 805002. https://doi.org/10.3389/fpsyt.2021.805002 Hoopsick, R. A., & Andrew Yockey, R. (2023). Methamphetamine-related mortality in the United States: Co-involvement of heroin and fentanyl, 1999-2021. American Journal of Public Health, 113(4), 416–419. https://doi.org/10.2105/AJPH.2022.307212 Husain, J. M., Cromartie, D., Fitzelle-Jones, E., Brochier, A., Borba, C. P., & Montalvo, C. (2023). A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations. Journal of Substance Abuse Treatment, 144, 108918. https://doi.org/10.1016/j.jsat.2022.108918 Ivsins, A., Fleming, T., Barker, A., Mansoor, M., Thakarar, K., Sue, K., & McNeil, R. (2022). The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids. International Journal of Drug Policy, 107, 103791. https://doi.org/10.1016/j.drugpo.2022.103791 Jardine, M., Crofts, N., Monaghan, G., & Morrow, M. G. (2012). Harm reduction and law enforcement in Vietnam: Influences on street policing. Harm Reduction Journal, 9(1), 27. https://doi.org/10.1186/1477-7517-9-27 Jones, C. M., Olsen, E. O., O’Donnell, J., & Mustaquim, D. (2020a). Resurgent methamphetamine use at treatment admission in the United States, 2008-2017. American Journal of Public Health, 110(4), 509–516. https://doi.org/10.2105/AJPH.2019.305527 Jones, C. M., Underwood, N., & Compton, W. M. (2020b). Increases in methamphetamine use among heroin treatment admissions in the United States, 2008–17. Addiction, 115(2), 347–353. https://doi.org/10.1111/add.14812 Karamouzian, M., Dohoo, C., Forsting, S., McNeil, R., Kerr, T., & Lysyshyn, M. (2018). Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada. Harm Reduction Journal, 15(1), 1–8. https://doi.org/10.1186/s12954-018-0252-8 Karamouzian, M., Buxton, J. A., Hategeka, C., Nosova, E., Hayashi, K., Milloy, M.-J., & Kerr, T. (2022a). Shifts in substance use patterns among a cohort of people who use opioids after delisting of OxyContin in BC, Canada: An interrupted time series study. International Journal of Drug Policy, 109, 103852. https://doi.org/10.1016/j.drugpo.2022.103852 Karamouzian, M., Pilarinos, A., Hayashi, K., Buxton, J. A., & Kerr, T. (2022b). Latent patterns of polysubstance use among people who use opioids: A systematic review. International Journal of Drug Policy, 102, 103584. https://doi.org/10.1016/j.drugpo.2022.103584 Karamouzian, M., Cui, Z., Hayashi, K., DeBeck, K., Milloy, M. J., Buxton, J. A., & Kerr, T. (2023). Longitudinal latent polysubstance use patterns among a cohort of people who use opioids in Vancouver, Canada. Drug and Alcohol Review. https://doi.org/10.1111/dar.13690 Kennedy, M. C., Karamouzian, M., & Kerr, T. (2017). Public health and public order outcomes associated with supervised drug consumption facilities: A systematic review. Current HIV/AIDS Reports, 14, 161–183. https://doi.org/10.1007/s11904-017-0363-y Keyes, K. M., Cerdá, M., Brady, J. E., Havens, J. R., & Galea, S. (2014). Understanding the rural–urban differences in nonmedical prescription opioid use and abuse in the United States. American Journal of Public Health, 104(2), e52–e59. https://doi.org/10.2105/AJPH.2013.301709 Knight, R., Karamouzian, M., Carson, A., Edward, J., Carrieri, P., Shoveller, J., . . . Fast, D. (2019). Interventions to address substance use and sexual risk among gay, bisexual and other men who have sex with men who use methamphetamine: A systematic review. Drug and Alcohol Dependence, 194, 410–429. https://doi.org/10.1016/j.drugalcdep.2018.09.023 Kolla, G., Kenny, K. S., Bannerman, M., Boyce, N., Chapman, L., Dodd, Z., Ko, J., & Ovens, S. (2020). Help me fix: The provision of injection assistance at an unsanctioned overdose prevention site in Toronto, Canada. International Journal of Drug Policy, 76, 102617. https://doi.org/10.1016/j.drugpo.2019.102617 Korthuis, P. T., Cook, R., Foot, C., Leichtling, G., Tsui, J. I., Stopka, T. J., Leahy, J., Jenkins, W. D., Baker, R., Chan, B., Crane, H. M., Cooper, H. L., Feinberg, J., Zule, W., Go, V. F., Estadt, A. T., Nance, R. M., Smith, G. S., Westergaard, R. P., . . . Young, A. M. (2022). Association of methamphetamine and opioid use with nonfatal overdose in rural communities. JAMA Network Open, 5(8), e2226544. https://doi.org/10.1001/jamanetworkopen.2022.26544 Kwon, N. J., & Han, E. (2018). A commentary on the effects of methamphetamine and the status of methamphetamine abuse among youths in South Korea, Japan, and China. Forensic Science International, 286, 81–85. https://doi.org/10.1016/j.forsciint.2018.02.022 Leece, P., Khorasheh, T., Corace, K., Strike, C., Bayoumi, A. M., Taha, S., Marks, E., Pach, B., Ahamad, K., Grennell, E., Holowaty, M., Manson, H., & Straus, S. E. (2019). Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review. BMJ Open, 9(12), e032285. https://doi.org/10.1136/bmjopen-2019-032285 Lewis, D., Kenneally, M., van denHeuvel, C., & Byard, R. W. (2021). Methamphetamine deaths: Changing trends and diagnostic issues. Medicine, Science and the Law, 61(2), 130–137. https://doi.org/10.1177/0025802420986707 Lin, H., Chang, R. Y., Wang, P., Wu, H., Yen, C., Yeh, Y., Chung, K., Chang, H., & Yen, C. (2013). Gender differences in heroin users receiving methadone maintenance therapy in Taiwan. Journal of Addictive Diseases, 32(2), 140–149. https://doi.org/10.1080/10550887.2013.795466 Lopez, A. M., Dhatt, Z., Howe, M., Al-Nassir, M., Billing, A., Artigiani, E., & Wish, E. D. (2021). Co-use of methamphetamine and opioids among people in treatment in Oregon: A qualitative examination of interrelated structural, community, and individual-level factors. International Journal of Drug Policy, 91, 103098. https://doi.org/10.1016/j.drugpo.2020.103098 Makarenko, I., Mazhnaya, A., Marcus, R., Pykalo, I., Madden, L. M., Filippovich, S., Dvoriak, S., & Altice, F. L. (2018). Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine. Journal of Substance Abuse Treatment, 87, 1–8. https://doi.org/10.1016/j.jsat.2018.01.007 Mamat, R., Nasrulddin, N. A. A., & Yusoff, N. A. M. (2020). Continued use of illicit substance among methadone treatment patients in primary health care clinics in east coast region of Malaysia. Alcoholism Treatment Quarterly, 38(2), 184–198. https://doi.org/10.1080/07347324.2019.1672600 Maynard, R., & Jozaghi, E. (2021). The drug war must end: The right to life, liberty and security of the person during the COVID-19 pandemic for people who use drugs. Harm Reduction Journal, 18(1). https://doi.org/10.1186/s12954-021-00474-8 Mckenna, S. A. (2013). We’re supposed to be asleep? Vigilance, paranoia, and the alert methamphetamine user. Anthropol Consciousness, 24(2), 172–190. https://doi.org/10.1111/anoc.12012 McKetin, R., Kozel, N., Douglas, J., Ali, R., Vicknasingam, B., Lund, J., & Li, J. H. (2008). The rise of methamphetamine in Southeast and East Asia. Drug and Alcohol Review, 27(3), 220–228. https://doi.org/10.1080/09595230801923710 Meacham, M. C., Rudolph, A. E., Strathdee, S. A., Rusch, M., Brouwer, K. C., Patterson, T. L., Vera, A., Rangel, G., & Roesch, S. C. (2015). Polydrug use and HIV risk among people who inject heroin in Tijuana, Mexico: A latent class analysis. Substance Use & Misuse, 50(10), 1351–1359. https://doi.org/10.3109/10826084.2015.1013132 Meacham, M. C., Roesch, S. C., Strathdee, S. A., & Gaines, T. L. (2018a). Perceived treatment need and latent transitions in heroin and methamphetamine polydrug use among people who inject drugs in Tijuana, Mexico. Journal of Psychoactive Drugs, 50(1), 62–71. https://doi.org/10.1080/02791072.2017.1370747 Meacham, M. C., Roesch, S. C., Strathdee, S. A., Lindsay, S., Gonzalez-Zuniga, P., & Gaines, T. L. (2018b). Latent classes of polydrug and polyroute use and associations with human immunodeficiency virus risk behaviours and overdose among people who inject drugs in Tijuana, Baja California, Mexico. Drug and Alcohol Review, 37(1), 128–136. https://doi.org/10.1111/dar.12524 Mehrpour, O. (2019). Take-home naloxone program is a priority in Iran. Journal of Research in Medical Sciences, 24(1), 111. https://doi.org/10.4103/jrms.jrms_480_19 Melendez-Torres, G. J., Bonell, C., Hickson, F., Bourne, A., Reid, D., & Weatherburn, P. (2016). Predictors of crystal methamphetamine use in a community-based sample of UK men who have sex with men. International Journal of Drug Policy, 36, 43–46. https://doi.org/10.1016/j.drugpo.2016.06.010 Murthy, V. H. (2016). Ending the opioid epidemic — A call to action. New England Journal of Medicine, 375(25), 2413–2415. https://doi.org/10.1056/nejmp1612578 National Institute on Drug Abuse. (2021). Opioid overdose crisis. National Institute on Drug Abuse. https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis. Accessed 2 June 2021. Nijman, J., & Wei, Y. D. (2020). Urban inequalities in the 21st century economy. Applied Geography, 117, 102188. https://doi.org/10.1016/j.apgeog.2020.102188 Onoka, I., Banyika, A. T., Banerjee, P. N., Makangara, J. J., & Dujourdy, L. (2020). A review of the newly identified impurity profiles in methamphetamine seizures. Forensic Science International: Synergy, 2, 194–205. https://doi.org/10.1016/j.fsisyn.2020.06.004 Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T., Mulrow, C. D., Shamseer, L., Tetzlaff, J., Akl, E. A., Brennan, S., Chou, R., Glanville, J., Grimshaw, J., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E., Mayo-Wilson, E., McDonald, S., . . . Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, n71. https://doi.org/10.1136/bmj.n71 Palamar, J. J., Cottler, L. B., Goldberger, B. A., Severtson, S. G., Grundy, D. J., Iwanicki, J. L., & Ciccarone, D. (2022). Trends in characteristics of fentanyl-related poisonings in the United States, 2015-2021. American Journal of Drug and Alcohol Abuse, 48(4), 471–480. https://doi.org/10.1080/00952990.2022.2081923 Palmer, A., Scott, N., Dietze, P., & Higgs, P. (2020). Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: A qualitative study. Harm Reduction Journal, 17(1), 14. https://doi.org/10.1186/s12954-020-00360-9 Park, J. N., Rouhani, S., Beletsky, L., Vincent, L., Saloner, B., & Sherman, S. G. (2020). Situating the continuum of overdose risk in the social determinants of health: A new conceptual framework. Milbank Quarterly, 98(3), 700–746. https://doi.org/10.1111/1468-0009.12470 Pauly, B., Wallace, B., Pagan, F., Phillips, J., Wilson, M., Hobbs, H., & Connolly, J. (2020). Impact of overdose prevention sites during a public health emergency in Victoria, Canada. PLoS ONE, 15(5). https://doi.org/10.1371/journal.pone.0229208 Pijl-Zieber, E. M., Alraja, A. A., Duff, E., Cooke, C., Dash, S., Nayak, N., Lamoureux, J., Poulin, G., Knight, E., & Fry, B. (2022). Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: An integrative review. Substance Abuse Treatment Prevention and Policy, 17(1). https://doi.org/10.1186/s13011-022-00463-5 Pilarinos, A., Bromberg, D. J., & Karamouzian, M. (2022). Access to medications for opioid use disorder and associated factors among adolescents and young adults: A systematic review. JAMA Pediatrics, 176(3), 304–311. https://doi.org/10.1001/jamapediatrics.2021.4606 Pitpitan, E. V., Semple, S. J., Zians, J., Strathdee, S. A., & Patterson, T. L. (2018). Mood, meth, condom use, and gender: Latent growth curve modeling results from a randomized trial. AIDS and Behavior, 22(9), 2815–2829. https://doi.org/10.1007/s10461-018-2147-9 Ramachandram, D. S., Chitra, V., & Rini, R. (2020). Current opioid access, use and problems in Asian jurisdictions. Research Journal of Pharmacy and Technology, 13(4), 1991. https://doi.org/10.5958/0974-360x.2020.00358.3 Redmond, N., Aminawung, J. A., Morse, D. S., Zaller, N., Shavit, S., & Wang, E. A. (2020). Perceived discrimination based on criminal record in healthcare settings and self-reported health status among formerly incarcerated individuals. Journal of Urban Health, 97(1), 105–111. https://doi.org/10.1007/s11524-019-00382-0 Rhed, B. D., Harding, R. W., Marks, C., Wagner, K. T., Fiuty, P., Page, K., & Wagner, K. D. (2022). Patterns of and rationale for the co-use of methamphetamine and opioids: Findings from qualitative interviews in New Mexico and Nevada. Frontiers in Psychiatry, 13, 824940. https://doi.org/10.3389/fpsyt.2022.824940 Rostami, M., Jalilian, A., Ghadirzadeh, M. R., Nazparvar, B., Rezaei-Zangeneh, R., & Karamouzian, M. (2023). Bayesian spatial analysis of age differences and geographical variations in illicit-drug-related mortality in the Islamic Republic of Iran. Eastern Mediterranean Health Journal, 29(1), 24–32. https://doi.org/10.26719/emhj.23.003 Russell, K., Dryden, D. M., Liang, Y., Friesen, C., O’Gorman, K., Durec, T., Wild, T. C., & Klassen, T. P. (2008). Risk factors for methamphetamine use in youth: A systematic review. BMC Pediatrics, 8(1). https://doi.org/10.1186/1471-2431-8-48 Shearer, R. D., Howell, B. A., Bart, G., & Winkelman, T. N. A. (2020). Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015-2018. Drug and Alcohol Dependence, 214, 108162. https://doi.org/10.1016/j.drugalcdep.2020.108162 Shukla, R. K., Crump, J. L., & Chrisco, E. S. (2012). An evolving problem: Methamphetamine production and trafficking in the United States. International Journal of Drug Policy, 23(6), 426–435. https://doi.org/10.1016/j.drugpo.2012.07.004 Silverstein, S. M., Daniulaityte, R., Getz, K., & Zule, W. (2021). “It’s crazy what meth can help you do”: Lay beliefs, practices, and experiences of using methamphetamine to self-treat symptoms of opioid withdrawal. Substance Use and Misuse, 56(11), 1687–1696. https://doi.org/10.1080/10826084.2021.1949612 Singh, D., Mamat, R. B., Narayanan, S., & Vicknasingam, B. (2019). Prevalence of amphetamine-type stimulants (ATS) use among clients in primary and private methadone maintenance treatment (MMT) program in Kuantan, Malaysia. Journal of Substance Use, 24(6), 666–671. https://doi.org/10.1080/14659891.2019.1642409 Singh, D., Kamal, W. M., Narayanan, S., & Vicknasingam, B. (2020). Methamphetamine use and misconceptions among primary and private methadone maintenance treatment (MMT) program attendees in Klang Valley, Malaysia. Journal of Substance Use, 25(5), 528–534. https://doi.org/10.1080/14659891.2020.1738573 Smith, K. E., Rogers, J. M., & Strickland, J. C. (2022). Associations of lifetime nonmedical opioid, methamphetamine, and kratom use within a nationally representative US sample. Journal of Psychoactive Drugs, 54(5), 429–439. https://doi.org/10.1080/02791072.2021.2006374 Spencer, M. R., Miniño, A. M., & Warner, M. (2022). Drug overdose deaths in the United States, 2001-2021. NCHS Data Brief, 457, 1–8. Steinberg, A., Mehta, A., Papamihali, K., Lukac, C. D., Young, S., Graham, B., Lock, K., Fleury, M., & Buxton, J. A. (2022). Motivations for concurrent use of uppers and downers among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 harm reduction client survey. BMJ Open, 12(5), e060447. https://doi.org/10.1136/bmjopen-2021-060447 Stoneberg, D. M., Shukla, R. K., & Magness, M. B. (2018). Global methamphetamine trends: An evolving problem. International Criminal Justice Review, 28(2), 136–161. https://doi.org/10.1177/1057567717730104 Strickland, J. C., Havens, J. R., & Stoops, W. W. (2019). A nationally representative analysis of “twin epidemics”: Rising rates of methamphetamine use among persons who use opioids. Drug and Alcohol Dependence, 204, 107592. https://doi.org/10.1016/j.drugalcdep.2019.107592 Strickland, J. C., Stoops, W. W., Dunn, K. E., Smith, K. E., & Havens, J. R. (2021). The continued rise of methamphetamine use among people who use heroin in the United States. Drug and Alcohol Dependence, 225, 108750. https://doi.org/10.1016/j.drugalcdep.2021.108750 Sylvestre, J., Klodawsky, F., Gogosis, E., Ecker, J., Polillo, A., Czechowski, K., Agha, A., Shankar, S., To, M. J., Gadermann, A. M., Palepu, A., & Hwang, S. W. (2018). Perceptions of housing and shelter among people with histories of unstable housing in three cities in Canada: A qualitative study. American Journal of Community Psychology, 61(3–4), 445–458. https://doi.org/10.1002/ajcp.12243 Tavakoli, M., Effatpanah, M., Moradi, A., & Mahjoub, A. (2018). Methamphetamine dependence among Iranian female methadone patients: A cross-sectional survey of three cities of Iran. Iranian Journal of Psychiatry and Behavioral Sciences, 12(2), e62866. https://doi.org/10.5812/ijpbs.62866 Taylor, J., Pardo, B., Hulme, S., Bouey, J., Greenfield, V. A., Zhang, S. X., & Kilmer, B. (2021). Illicit synthetic opioid consumption in Asia and the Pacific: Assessing the risks of a potential outbreak. Drug and Alcohol Dependence, 220, 108500. https://doi.org/10.1016/j.drugalcdep.2020.108500 Twillman, R. K., Dawson, E., LaRue, L., Guevara, M. G., Whitley, P., & Huskey, A. (2020). Evaluation of trends of near-real-time urine drug test results for methamphetamine, cocaine, heroin, and fentanyl. JAMA Network Open, 3(1), e1918514. https://doi.org/10.1001/jamanetworkopen.2019.18514 UNODC. (2022). World drug report 2022. United Nations publication. https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2022.html. Accessed 23 Feb 2023. Vale de Andrade, P., & Carapinha, L. (2010). Drug decriminalisation in Portugal. BMJ, 341. https://doi.org/10.1136/bmj.c4554 Van Draanen, J., Tsang, C., Mitra, S., Karamouzian, M., & Richardson, L. (2020). Socioeconomic marginalization and opioid-related overdose: A systematic review. Drug and Alcohol Dependence, 214, 108127. https://doi.org/10.1016/j.drugalcdep.2020.108127 Van Draanen, J., Jamula, R., Karamouzian, M., Mitra, S., & Richardson, L. (2023). Pathways connecting socioeconomic marginalization and overdose: A qualitative narrative synthesis. International Journal of Drug Policy, 113, 103971. https://doi.org/10.1016/j.drugpo.2023.103971 Vearrier, D., Greenberg, M. I., Miller, S. N., Okaneku, J. T., & Haggerty, D. A. (2012). Methamphetamine: History, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Disease-a-Month, 58(2), 38–89. https://doi.org/10.1016/j.disamonth.2011.09.004 Vicknasingam, B., Dazali, M. N. M., Singh, D., Schottenfeld, R. S., & Chawarski, M. C. (2015). Buprenorphine/naloxone treatment practices in Malaysia: Results of national surveys of physicians and patients. Drug and Alcohol Dependence, 152, 164–169. https://doi.org/10.1016/j.drugalcdep.2015.04.007 Von Hoffmann, J. (2016). The international dimension of drug policy reform in Uruguay. International Journal of Drug Policy, 34, 27–33. https://doi.org/10.1016/j.drugpo.2016.04.015 Wakeman, S. E., & Rich, J. D. (2017). Barriers to post-acute care for patients on opioid agonist therapy; An example of systematic stigmatization of addiction. Journal of General Internal Medicine, 32(1), 17–19. https://doi.org/10.1007/s11606-016-3799-7 Wallace, B., Pagan, F., & Pauly, B. (2019). The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency. International Journal of Drug Policy, 66, 64–72. https://doi.org/10.1016/j.drugpo.2019.01.017 Wang, R., Ding, Y., Bai, H., Duan, S., Ye, R., Yang, Y., Wang, J., Tang, R., Gao, M., & He, N. (2015). Illicit heroin and methamphetamine use among methadone maintenance treatment patients in Dehong prefecture of Yunnan Province, China. PLOS ONE, 10(7), e0133431. https://doi.org/10.1371/journal.pone.0133431 Wells, G., Shea, B., O’Connell, D., & Peterson, J. (2000). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp